TrialJournal for immunotherapy of cancer2021

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist.

Max O Meneveau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.